Clinical Trials Logo
  1. Home
  2. Polycystic Ovary Syndrome (PCOS)
  3. NCT01720459

Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients

Polycystic Ovary Syndrome (PCOS) Clinical Trial

Official title:
Effects of Micronized Trans-resveratrol Treatment on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Placebo-controlled Randomized Single-blind Study

Clinical Trial Summary

The purpose of this study is to determine whether micronized trans-resveratrol improves clinical (excessive hair, menstrual cycle), endocrine (androgens)and metabolic (lipids, markers of systemic inflammation) in women with polycystic ovary syndrome (PCOS).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01720459
Study type Interventional
Source Poznan University of Medical Sciences
Contact Beata Banaszewska, MD PhD
Phone +48 61 8419412
Email bbeata48@gmail.com
Status Not yet recruiting
Phase N/A
Start date December 2012
Completion date December 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06306417 - A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome N/A
Completed NCT01927471 - Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Completed NCT01927432 - Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
Completed NCT00805207 - Sex Steroids, Sleep, and Metabolic Dysfunction in Women N/A
Completed NCT01999686 - PCOS Treatment Using DLBS3233, Metformin, and Combination of Both Phase 3
Completed NCT03414957 - Malay Women With PCOS and Their Association With Metabolic Syndrome
Recruiting NCT06143527 - Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS Phase 1
Recruiting NCT05394142 - A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS) Phase 2
Completed NCT01233206 - Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles Phase 4
Not yet recruiting NCT05272657 - Low-Carb Versus Mediterranean Diet in PCOS N/A
Completed NCT01733459 - Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) Phase 3
Completed NCT04264832 - Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome
Completed NCT03547453 - Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
Terminated NCT02865915 - MLE4901 vs. Placebo for the Treatment of PCOS Phase 2
Completed NCT02429128 - 14 Weeks Exercise Training on Lean Women With and Without PCOS N/A
Completed NCT01899001 - Mood and Nutrition Interventions in Polycystic Ovary Syndrome N/A
Completed NCT03151005 - The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS Phase 4
Completed NCT03792282 - Time-Restricted Feeding(TRF) on Overweight/Obese Women With Polycystic Ovarian Syndrome (PCOS) N/A
Completed NCT04852510 - Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin Phase 2/Phase 3
Recruiting NCT05200793 - Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome Phase 4